Hepatitis C virus (HCV) is an oncogenic virus associated with the onset of
hepatocellular carcinoma (HCC). The present study investigated the possible link between HCV
infection and
Netrin-1, a
ligand for dependence receptors that sustains
tumorigenesis, in particular in
inflammation-associated
tumors. We show that
Netrin-1 expression is significantly elevated in HCV+ liver biopsies compared to hepatitis B virus (HBV+) and uninfected samples. Furthermore,
Netrin-1 was upregulated in all histological stages of HCV+ hepatic lesions, from minimal
liver fibrosis to
cirrhosis and HCC, compared to histologically matched HCV- tissues. Both
cirrhosis and HCV contributed to the induction of
Netrin-1 expression, whereas anti-HCV treatment resulted in a reduction of
Netrin-1 expression. In vitro, HCV increased the level and translation of
Netrin-1 in a NS5A-La-related
protein 1 (LARP1)-dependent fashion. Knockdown and forced expression experiments identified the receptor uncoordinated receptor-5 (UNC5A) as an antagonist of the
Netrin-1 signal, though it did not affect the death of HCV-infected cells.
Netrin-1 enhanced infectivity of HCV particles and promoted viral entry by increasing the activation and decreasing the recycling of the
epidermal growth factor receptor (EGFR), a
protein that is dysregulated in HCC.
Netrin-1 and HCV are, therefore, reciprocal inducers in vitro and in patients, as seen from the increase in viral morphogenesis and viral entry, both phenomena converging toward an increase in the level of infectivity of HCV virions. This functional association involving a
cancer-related virus and
Netrin-1 argues for evaluating the implication of UNC5 receptor
ligands in other oncogenic microbial species.